Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Allergic Rhinitis

Interventions

DRUG

GSK1004723 (200mg)

Intranasal antihistamine.

OTHER

Placebo

Equivalent to GSK1004723 in presentation etc.

DRUG

GSK1004723 (1000mg)

Intranasal antihistamine.

Trial Locations (1)

GSK Investigational Site, Hanover